Materials & Resources » Chemicals | Cambrex Corp.

Cambrex Corp.

Cambrex Corp.
Stock Exchange New York Stock Exchange
EPS
 $2.33
Market Cap
 $1.59 B
Shares Outstanding
 33.66 M
Public Float
 33.2 M

Profile

Address
One Meadowlands Plaza
East Rutherford New Jersey 07073
United States
Employees -
Website http://www.cambrex.com
Updated 07/08/2019
Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies. Its products include generic and branded APIs, controlled substances, chiral compounds, high potency APIs, and advanced intermediates.

Financials

View All
Created with Highcharts 5.0.14Cambrex Corp.Net Income. Fiscal year is January-December. All values USD Thousands.30 27530 27558 13358 13357 17657 17687 32587 325103 764103 76493 20993 209201320142015201620172018025k50k75k100k125k
Created with Highcharts 5.0.14Cambrex Corp.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.318 309318 309374 427374 427433 931433 931490 338490 338535 006535 006531 185531 1852013201420152016201720180100k200k300k400k500k600k

Steven M. Klosk
President, Chief Executive Officer & Director
Greg B. Brown
Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.